12,281 Shares in CME Group Inc. $CME Acquired by Foyston Gordon & Payne Inc

Foyston Gordon & Payne Inc acquired a new stake in shares of CME Group Inc. (NASDAQ:CME) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 12,281 shares of the financial services provider’s stock, valued at approximately $2,712,000.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Bridgewater Advisors Inc. acquired a new stake in CME Group in the 2nd quarter worth approximately $612,000. FLC Capital Advisors bought a new stake in CME Group during the fourth quarter worth approximately $2,122,000. HighTower Advisors LLC grew its holdings in CME Group by 6.9% during the fourth quarter. HighTower Advisors LLC now owns 352,922 shares of the financial services provider’s stock valued at $96,376,000 after purchasing an additional 22,692 shares during the last quarter. TD Private Client Wealth LLC grew its holdings in CME Group by 132.7% during the fourth quarter. TD Private Client Wealth LLC now owns 21,228 shares of the financial services provider’s stock valued at $5,797,000 after purchasing an additional 12,105 shares during the last quarter. Finally, North Dakota State Investment Board bought a new position in shares of CME Group in the fourth quarter valued at approximately $3,368,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at CME Group

In other news, Director William R. Shepard acquired 325 shares of the company’s stock in a transaction dated Thursday, June 25th. The stock was bought at an average price of $230.57 per share, with a total value of $74,935.25. Following the completion of the acquisition, the director owned 260,442 shares in the company, valued at approximately $60,050,111.94. This represents a 0.12% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.30% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on CME. Morgan Stanley boosted their price objective on shares of CME Group from $324.00 to $330.00 and gave the stock an “overweight” rating in a research note on Thursday, July 23rd. Raymond James Financial reiterated an “outperform” rating and issued a $320.00 target price on shares of CME Group in a research note on Thursday, July 2nd. Erste Group Bank downgraded shares of CME Group from a “buy” rating to a “hold” rating in a report on Friday, June 5th. Rothschild & Co Redburn raised shares of CME Group from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $316.00 to $323.00 in a research report on Thursday, June 11th. Finally, Keefe, Bruyette & Woods upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price target for the company in a report on Thursday, June 18th. Nine analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $288.56.

CME Group Stock Performance

Shares of NASDAQ CME opened at $274.98 on Friday. The business has a fifty day simple moving average of $251.17 and a 200 day simple moving average of $279.65. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a market capitalization of $98.88 billion, a price-to-earnings ratio of 23.32, a PEG ratio of 3.20 and a beta of 0.23. CME Group Inc. has a one year low of $218.31 and a one year high of $329.16.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.08. The business had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The firm’s revenue was up .8% on a year-over-year basis. During the same period in the previous year, the business earned $2.96 EPS. Sell-side analysts expect that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be issued a dividend of $1.30 per share. The ex-dividend date of this dividend is Wednesday, September 9th. This represents a $5.20 annualized dividend and a dividend yield of 1.9%. CME Group’s dividend payout ratio (DPR) is presently 44.11%.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.